- Home
- CCCX vs CMPX Comparison
CCCX vs CMPX Comparison
Compare CCCX & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCX
- CMPX
- Stock Information
- Founded
- CCCX 2024
- CMPX 2014
- Country
- CCCX United States
- CMPX United States
- Employees
- CCCX N/A
- CMPX N/A
- Industry
- CCCX Blank Checks
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- CCCX Finance
- CMPX Health Care
- Exchange
- CCCX Nasdaq
- CMPX Nasdaq
- Market Cap
- CCCX 681.3M
- CMPX 730.9M
- IPO Year
- CCCX 2025
- CMPX N/A
- Fundamental
- Price
- CCCX $20.36
- CMPX $4.03
- Analyst Decision
- CCCX
- CMPX Strong Buy
- Analyst Count
- CCCX 0
- CMPX 7
- Target Price
- CCCX N/A
- CMPX $14.71
- AVG Volume (30 Days)
- CCCX 7.9M
- CMPX 1.9M
- Earning Date
- CCCX 01-01-0001
- CMPX 11-11-2025
- Dividend Yield
- CCCX N/A
- CMPX N/A
- EPS Growth
- CCCX N/A
- CMPX N/A
- EPS
- CCCX 0.14
- CMPX N/A
- Revenue
- CCCX N/A
- CMPX N/A
- Revenue This Year
- CCCX N/A
- CMPX N/A
- Revenue Next Year
- CCCX N/A
- CMPX N/A
- P/E Ratio
- CCCX $150.38
- CMPX N/A
- Revenue Growth
- CCCX N/A
- CMPX N/A
- 52 Week Low
- CCCX $10.03
- CMPX $1.27
- 52 Week High
- CCCX $27.50
- CMPX $4.86
- Technical
- Relative Strength Index (RSI)
- CCCX N/A
- CMPX 53.07
- Support Level
- CCCX N/A
- CMPX $3.86
- Resistance Level
- CCCX N/A
- CMPX $4.86
- Average True Range (ATR)
- CCCX 0.00
- CMPX 0.31
- MACD
- CCCX 0.00
- CMPX -0.05
- Stochastic Oscillator
- CCCX 0.00
- CMPX 38.43
About CCCX Churchill Capital Corp X Class A Ordinary Shares
Churchill Capital Corp X is a blank check company.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.